Literature DB >> 8389453

Identification of a poxvirus gene encoding a uracil DNA glycosylase.

C Upton1, D T Stuart, G McFadden.   

Abstract

An open reading frame, BamHI D6R, from the central highly conserved region of the Shope fibroma virus (SFV) genome was sequenced and found to have significant homology to that of uracil DNA glycosylases from a number of organisms. Uracil DNA glycosylase catalyzes the initial step in the repair pathway that removes potentially mutagenic uracil from duplex DNA. The D6R polypeptide was expressed in reticulocyte lysates programmed with RNA transcribed from an expression vector containing the T7 RNA polymerase promoter. A highly specific ethidium bromide fluorescence assay of the in vitro translation product determined that the encoded protein does indeed possess uracil DNA glycosylase activity. Open reading frames from other poxviruses, including vaccinia virus (HindIII D4R) and fowlpox (D4), are highly homologous to D6R of SFV and are predicted to encode uracil DNA glycosylases. Identification of the SFV uracil DNA glycosylase provides evidence that this poxviral protein is involved in the repair of the viral DNA genome. Since this enzyme performs only the initial step required for the removal of uracil from DNA, creating an apyrimidinic site, we suggest that other, possibly virus-encoded, repair activities must be present in the cytoplasm of infected cells to complete the uracil excision repair pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8389453      PMCID: PMC46543          DOI: 10.1073/pnas.90.10.4518

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Sequence and analysis of the BamHI "D" fragment of Shope fibroma virus: comparison with similar regions of related poxviruses.

Authors:  D S Strayer; H H Jerng
Journal:  Virus Res       Date:  1992-09-01       Impact factor: 3.303

2.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Rapid sensitive fluorescence assays for DNA endonucleases and DNA glycosylases.

Authors:  D H Evans; F X Bugeja; B J Yacyshyn; A R Morgan
Journal:  Can J Biochem Cell Biol       Date:  1984-12

4.  Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing.

Authors:  F Sanger; A R Coulson; B G Barrell; A J Smith; B A Roe
Journal:  J Mol Biol       Date:  1980-10-25       Impact factor: 5.469

5.  Fine structure analysis and nucleotide sequence of the vaccinia virus thymidine kinase gene.

Authors:  D E Hruby; R A Maki; D B Miller; L A Ball
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

6.  Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects.

Authors:  S Dales; V Milovanovitch; B G Pogo; S B Weintraub; T Huima; S Wilton; G McFadden
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

7.  Biogenesis of poxviruses: preliminary characterization of conditional lethal mutants of vaccinia virus defective in DNA synthesis.

Authors:  G McFadden; S Dales
Journal:  Virology       Date:  1980-05       Impact factor: 3.616

8.  Vectors for selective expression of cloned DNAs by T7 RNA polymerase.

Authors:  A H Rosenberg; B N Lade; D S Chui; S W Lin; J J Dunn; F W Studier
Journal:  Gene       Date:  1987       Impact factor: 3.688

9.  Identification and nucleotide sequence of the thymidine kinase gene of Shope fibroma virus.

Authors:  C Upton; G McFadden
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

10.  The complete DNA sequence of varicella-zoster virus.

Authors:  A J Davison; J E Scott
Journal:  J Gen Virol       Date:  1986-09       Impact factor: 3.891

View more
  35 in total

1.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.

Authors:  A D Garcia; B Moss
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Role of vaccinia virus A20R protein in DNA replication: construction and characterization of temperature-sensitive mutants.

Authors:  K Ishii; B Moss
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 4.  DNA glycosylases in the base excision repair of DNA.

Authors:  H E Krokan; R Standal; G Slupphaug
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 5.  Poxvirus DNA replication.

Authors:  Bernard Moss
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

Review 6.  The vaccinia virus DNA polymerase and its processivity factor.

Authors:  Maciej W Czarnecki; Paula Traktman
Journal:  Virus Res       Date:  2017-02-01       Impact factor: 3.303

7.  Identification of non-nucleoside DNA synthesis inhibitors of vaccinia virus by high-throughput screening.

Authors:  Mihai Ciustea; Janice Elaine Y Silverman; Abigail M Druck Shudofsky; Robert P Ricciardi
Journal:  J Med Chem       Date:  2008-09-23       Impact factor: 7.446

8.  Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability.

Authors:  K S Ellison; W Peng; G McFadden
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Construction of a vaccinia virus deficient in the essential DNA repair enzyme uracil DNA glycosylase by a complementing cell line.

Authors:  G W Holzer; F G Falkner
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

10.  Effects of vaccinia virus uracil DNA glycosylase catalytic site and deoxyuridine triphosphatase deletion mutations individually and together on replication in active and quiescent cells and pathogenesis in mice.

Authors:  Frank S De Silva; Bernard Moss
Journal:  Virol J       Date:  2008-12-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.